Ivan Ranđelović
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Metal complexes synthesis and properties
- Pancreatic and Hepatic Oncology Research
Papers in
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 15
-
- Chemical Synthesis and Analysis 12
- RNA Interference and Gene Delivery 7
- Protein Kinase Regulation and GTPase Signaling 4
- Co-authors
- József Tóvári (28 shared papers)Gábor Mező (12 shared papers)Beáta Biri‐Kovács (6 shared papers)Gitta Schlosser (5 shared papers)Ines Neundorf (1 shared paper)Bálint Szeder (1 shared paper)Klaus Schomäcker (1 shared paper)Danijela Maksimović‐Ivanić (3 shared papers)
In The Last Decade
Ivan Ranđelović
29 papers receiving 395 citations
Peers
Comparison fields: 5 of 40
- Biomaterials 112
- Oncology 73
- Immunology and Allergy 15
- Molecular Biology 180
- Organic Chemistry 65
Countries citing papers authored by Ivan Ranđelović
This map shows the geographic impact of Ivan Ranđelović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Ranđelović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Ranđelović more than expected).
Fields of papers citing papers by Ivan Ranđelović
This network shows the impact of papers produced by Ivan Ranđelović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Ranđelović. The network helps show where Ivan Ranđelović may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Ranđelović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 44 | |
| 2 | 2019 | 33 | |
| 3 | 2020 | 31 | |
| 4 | 2019 | 29 | |
| 5 | 2013 | 28 | |
| 6 | 2023 | 23 | |
| 7 | 2024 | 23 | |
| 8 | 2019 | 20 | |
| 9 | 2018 | 19 | |
| 10 | 2018 | 19 | |
| 11 | 2019 | 18 | |
| 12 | 2014 | 14 | |
| 13 | 2021 | 12 | |
| 14 | 2023 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 6 |
About Ivan Ranđelović
Ivan Ranđelović is a scholar working on Biomaterials, Molecular Biology, Organic Chemistry, Oncology and Cancer Research, having authored 32 papers that have together received 399 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Chemical Synthesis and Analysis (12 papers), RNA Interference and Gene Delivery (7 papers), Synthesis and biological activity (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Metal complexes synthesis and properties (3 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Biomaterials (112 citations), Oncology (73 citations), Immunology and Allergy (15 citations), Molecular Biology (180 citations) and Organic Chemistry (65 citations). Ivan Ranđelović has collaborated with scholars based in Hungary, Germany and Italy. Frequent co-authors include József Tóvári, Gábor Mező, Beáta Biri‐Kovács, Gitta Schlosser, Ines Neundorf, Bálint Szeder, Klaus Schomäcker, Danijela Maksimović‐Ivanić, Goran N. Kaluđerović and Sanja Mijatović. Their work appears in journals such as International Journal of Molecular Sciences, European Journal of Medicinal Chemistry, ChemMedChem, Cancers and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.